About 300 reports

  • Clinical Trial profile. 295 Trial Title
  • Official Title

CLINICAL TRIALS BY PHASE IN E## COUNTRIES LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LIVER TRANSPLANT REJECTION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LIVER TRANSPLANT REJECTION THER

  • Biopharmaceutical
  • Clinical Trial
  • Drug Development
  • Liver Transplant
  • Novartis AG
  • CELLULAR IMMUNOTHERAPY FOR LIVER TRANSPLANTATION - DRUG PROFILE
  • CELLULAR IMMUNOTHERAPY FOR LIVER TRANSPLANT REJECTION - DRUG PROFILE

Liver transplant replaces an injured or diseased liver with a healthy one.

  • Biopharmaceutical
  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Therapy
  • Transplantation
  • PIPELINE BY DOMPE FARMACEUTICI SPA, H2 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018

Patients for liver transplantation will be recruited into the clinical trial that is scheduled to start in September 2013.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • RITUXIMAB BIOSIMILAR - DRUG PROFILE

The molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are ##, ##, ## and ## respectively.

  • Biopharmaceutical
  • Biosimilar
  • Therapy
  • World
  • ChemoCentryx, Inc.

The patient with grade ## AST had tumor progression to the liver.

  • Autoimmune Disease
  • Biopharmaceutical
  • Pharmaceutical
  • Research And Development
  • Therapy
  • PIPELINE BY DOMPE FARMACEUTICI SPA, H1 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018

Patients for liver transplantation will be recruited into the clinical trial that is scheduled to start in September 2013.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • PIPELINE BY ALEXION PHARMACEUTICALS INC, H2 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018 (CONTD..2), H2 2018

It also offers drugs to aid kidney, liver and other organ transplantations.

  • Autoimmune Disease
  • Biopharmaceutical
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Clinical Trial profile. 83 Trial Title

CHRONIC LIVER DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2019* CLINICAL TRIALS BY END POINT STATUS CHRONIC LIVER DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2019* CHRONIC LIVER DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY

  • Biopharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Shionogi & Co., Ltd.

According to the United Network for Organ Sharing (" UNOS" ) there have been ##, ## liver transplants performed between January ##, 1988 and July ##, 2018.

  • Autoimmune Disease
  • Biopharmaceutical
  • Pharmaceutical
  • Therapy
  • Pfizer Inc.

PRIOR TREATMENT WITH RUX OR OTHER JAK INHIBITORS, ELIGIBILITY FOR ALLOGENEIC STEM CELL TRANSPLANTATION, INADEQUATE LIVER FUNCTION, AND SEVERELY IMPAIRED RENAL FUNCTION ARE KEY EXCLUSION CRITERIA.

  • Autoimmune Disease
  • Biopharmaceutical
  • Hospital
  • Pharmaceutical
  • Therapy
  • Clinical Trial profile. 751 Trial Title
  • Clinical Trial profile. 748 Trial Title

A Combined Experimental Study and Clinical Trial Stem Cells as an Alternative Therapy to Liver Transplantation.

  • Biopharmaceutical
  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • World

Currently there are ##, ## individuals on the waiting list for a liver transplant.

  • Biopharmaceutical
  • Medical Biotechnology
  • United States
  • Product Initiative
  • Pfizer Inc.
  • RITUXIMAB BIOSIMILAR - DRUG PROFILE

Significant survival advantages for the abatacept group were demonstrated at one-year post-transplant.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY DOMPE FARMACEUTICI SPA, H1 2018
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY TOP 10 INDICATIONS, H1 2018

Patients for liver transplantation will be recruited into the clinical trial that is scheduled to start in September 2013.

  • Biopharmaceutical
  • Protein Therapy
  • Therapy
  • World
  • Product Initiative
  • PIPELINE BY NOVARTIS AG, H2 2018

The drug candidate is in Phase II stage of development for the treatment of primary Sjogren' s syndrome, myasthenia gravis, lupus nephritis and Grave' s hyperthyroidism, liver and renal transplant rejection and is in Phase I for rheumatoid arthritis.

  • Biopharmaceutical
  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy

Treatment includes liver transplant surgery.

  • Biopharmaceutical
  • Digestive System Disorder
  • Therapy
  • United States
  • Galectin Therapeutics Inc.

AS OF NOVEMBER 2008, COMPANY TERMINATED A PHASE I STUDY IN ALLOGENEIC BONE MARROW TRANSPLANT (BMT).

  • Biopharmaceutical
  • Healthcare
  • Hospital
  • Immunotherapy
  • Therapy
  • CARMA PLATFORM

Stem cell transplantation.

  • Biopharmaceutical
  • Immunotherapy
  • Medical Biotechnology
  • World
  • Novartis AG

GLOBAL STEM CELL TECHNOLOGIES AND APPLICATIONS MARKET 2018-2028 ##.

  • Biopharmaceutical
  • Cell Therapy
  • Medical Biotechnology
  • World
  • ravulizumab
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..2), H1 2018

It also offers drugs to aid kidney, liver and other organ transplantations.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.
  • Clinical Trial profile. 321 Trial Title

Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Estimated Start Date Actual Start date Estimated Completion Date # of Subjects Planned # of Location(s) #

  • Biopharmaceutical
  • Cancer
  • Chemotherapy
  • Clinical Trial
  • Therapy
  • Clinical Trial profile. 224 Trial Title
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Biopharmaceutical
  • Clinical Trial
  • Leukemia
  • Pharmaceutical
  • Transplantation
  • Oct 09, 2017: International Stem Cell Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
  • Aug 06, 2018: International Stem Cell developed 3D liver structures

According to the American Liver Foundation, approximately ##, ## patients are on the U. S. liver transplant waiting list with only ##, ## liver transplants performed each year.

  • Biopharmaceutical
  • Cell Therapy
  • United States
  • Company Financials
  • ISCC

These liver biomarkers have been shown to be reasonably likely to predict progression to liver failure and resulting liver transplant or premature death in patients with PBC.

  • Autoimmune Disease
  • Biopharmaceutical
  • United States
  • Product Initiative
  • Intercept Pharmaceuticals, Inc.
  • DORMANT PRODUCTS, H1 2018 (CONTD..2), H1 2018

The patient with grade ## AST had tumor progression to the liver.

  • Biopharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

THE DRUG CANDIDATE IS IN PHASE II STAGE OF DEVELOPMENT FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS, NONALCOHOLIC FATTY LIVER DISEASE, HCV RECURRENCE POST TRANSPLANT, RENAL IMPAIREMENT, AUTOIMMUNE HEPATITIS, PORTAL HYPERTENSION, ACUTE-ONCHRONIC LIVER FAILURE,

  • Biopharmaceutical
  • Chemotherapy
  • Digestive System Disorder
  • Therapy
  • Conatus Pharmaceuticals Inc.
  • DEC 14, 2017: RESEARCH TARGETING DIABETES, LIVER FAILURE AND HIV GET SUPPORT FROM CALIFORNIA STEM CELL AGENCY

UCLA doctors performed ## liver transplants in 2016.

  • Biopharmaceutical
  • Cancer
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy

The prominent features of this report are - ##.

  • Biopharmaceutical
  • Pharmaceutical
  • World
  • Product Initiative
  • Conatus Pharmaceuticals Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2019
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H1 2019

Patients for liver transplantation will be recruited into the clinical trial that is scheduled to start in September 2013.

  • Biopharmaceutical
  • Immunotherapy
  • United States
  • World
  • Product Initiative

Liver transplantation is the treatment option for patients with liver failure and hepatocellular carcinoma.

  • Biopharmaceutical
  • Pharmaceutical
  • South Korea
  • M&A
  • Green Cross